Relevant bibliographies by topics / Tissue engineering

Academic literature on the topic 'Tissue engineering'

Author: Grafiati
Published: 4 June 2021
Last updated: 14 September 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tissue engineering.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tissue engineering"

1

Feng, Wei, Yoke San Wong, and Dietmar W. Hutmacher. "The Application of Image Processing Software for Tissue Engineering(Cellular & Tissue Engineering)." Proceedings of the Asian Pacific Conference on Biomechanics : emerging science and technology in biomechanics 2004.1 (2004): 95–96. http://dx.doi.org/10.1299/jsmeapbio.2004.1.95.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Toh, S. L., S. W. Goh, S. Y. Lau, W. L. Teng, J. C. Goh, H. W. Ouyang, and T. E. Tay. "Mechanical Characterisation of Knitted/Woven Scaffolds for Tissue Engineering Applications(Cellular & Tissue Engineering)." Proceedings of the Asian Pacific Conference on Biomechanics : emerging science and technology in biomechanics 2004.1 (2004): 97–98. http://dx.doi.org/10.1299/jsmeapbio.2004.1.97.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alsberg, E., E. E. Hill, and D. J. Mooney. "Craniofacial Tissue Engineering." Critical Reviews in Oral Biology & Medicine 12, no. 1 (January 2001): 64–75. http://dx.doi.org/10.1177/10454411010120010501.

Full text
Abstract:
There is substantial need for the replacement of tissues in the craniofacial complex due to congenital defects, disease, and injury. The field of tissue engineering, through the application of engineering and biological principles, has the potential to create functional replacements for damaged or pathologic tissues. Three main approaches to tissue engineering have been pursued: conduction, induction by bioactive factors, and cell transplantation. These approaches will be reviewed as they have been applied to key tissues in the craniofacial region. While many obstacles must still be overcome prior to the successful clinical restoration of tissues such as skeletal muscle and the salivary glands, significant progress has been achieved in the development of several tissue equivalents, including skin, bone, and cartilage. The combined technologies of gene therapy and drug delivery with cell transplantation will continue to increase treatment options for craniofacial cosmetic and functional restoration.
APA, Harvard, Vancouver, ISO, and other styles
4

Hardingham, Tim. "Tissue engineering: Designing for health." Biochemist 25, no. 5 (October 1, 2003): 19–21. http://dx.doi.org/10.1042/bio02505019.

Full text
Abstract:
The tissue engineering that is now emerging in biomedical research groups is concerned with living tissues and how we can harness biological processes to achieve healing and repair, where it is otherwise failing. It aims to develop our scientific understanding of how living cells function, so that we can gain control and direct their activity to the promote the repair of damaged and diseased tissue1.
APA, Harvard, Vancouver, ISO, and other styles
5

Kishida, Akio, Seiichi Funamoto, Jun Negishi, Yoshihide Hashimoto, Kwangoo Nam, Tsuyoshi Kimura, Toshiya Fujisato, and Hisatoshi Kobayashi. "Tissue Engineering with Natural Tissue Matrices." Advances in Science and Technology 76 (October 2010): 125–32. http://dx.doi.org/10.4028/www.scientific.net/ast.76.125.

Full text
Abstract:
Natural tissue, especially autologous tissue is one of ideal materials for tissue regeneration. Decellularized tissue could be assumed as a second choice because the structure and the mechanical properties are well maintained. Decellularized human tissues, for instance, heart valve, blood vessel, and corium, have already been developed and applied clinically. Nowadays, decellularized porcine tissues are also investigated. These decellularized tissues were prepared by detergent treatment. The detergent washing is easy but sometime it has problems. We have developed the novel decellularization method, which applied the high-hydrostatic pressure (HHP). As the tissue set in the pressurizing chamber is treated uniformly, the effect of the high-hydrostatic pressurization does not depend on the size of tissue. We have reported the HHP decellularization of heart valve, blood vessel, bone, and cornea. Furthermore, HHP treatments are reported to have the ability of the extinction of bacillus and the inactivation of virus. So, the HHP treatment is also expected as the sterilization method. We are investigating efficient processes of decellularization and recellularization of biological tissues to have bioscaffolds keeping intact structure and biomechanical properties. Our recent studies on tissue engineering using HHP decellularized tissue will be reported here.
APA, Harvard, Vancouver, ISO, and other styles
6

Bakhshandeh, Behnaz, Payam Zarrintaj, Mohammad Omid Oftadeh, Farid Keramati, Hamideh Fouladiha, Salma Sohrabi-jahromi, and Zarrintaj Ziraksaz. "Tissue engineering; strategies, tissues, and biomaterials." Biotechnology and Genetic Engineering Reviews 33, no. 2 (July 3, 2017): 144–72. http://dx.doi.org/10.1080/02648725.2018.1430464.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Boschetti, Federica. "Tissue Mechanics and Tissue Engineering." Applied Sciences 12, no. 13 (June 30, 2022): 6664. http://dx.doi.org/10.3390/app12136664.

Full text
Abstract:
Tissue engineering (TE) combines scaffolds, cells, and chemical and physical cues to replace biological tissues. Several disciplines, such as biology, chemistry, materials science, mathematics, and most branches of engineering, support this goal while improving the quality of the reconstructed tissues [...]
APA, Harvard, Vancouver, ISO, and other styles
8

Singh, Mandeep, Sanjeet Singh, Nishant Singh, Paramjit Singh, Kanika Sharma, and Neeraj Grover. "ORAL TISSUE ENGINEERING." International Journal of Advanced Research 12, no. 02 (February 29, 2024): 467–69. http://dx.doi.org/10.21474/ijar01/18318.

Full text
Abstract:
Oral tissue engineering is a progressive field aiming to regenerate damaged oral tissues, such as bone, gums, and salivary glands, by leveraging a combination of scaffolds, cells, and bioactive molecules. This multidisciplinary approach integrates principles from biology, materials science, and engineering to develop functional replacements for lost or injured oral tissues. Recent advancements have focused on optimizing scaffold materials to mimic the natural oral environment, identifying suitable cell sources for regeneration, and applying growth factors to enhance tissue repair and integration. These innovations offer promising avenues for improving dental and craniofacial reconstructive treatments, significantly impacting patient care in dentistry and oral surgery.
APA, Harvard, Vancouver, ISO, and other styles
9

Matoka, Derek J., and Earl Y. Cheng. "Tissue engineering in urology." Canadian Urological Association Journal 3, no. 5 (May 1, 2013): 403. http://dx.doi.org/10.5489/cuaj.1155.

Full text
Abstract:
Tissue engineering encompasses a multidisciplinary approach gearedtoward the development of biological substitutes designed to restoreand maintain normal function in diseased or injured tissues. Thisarticle reviews the basic technology that is used to generateimplantable tissue-engineered grafts in vitro that will exhibit characteristicsin vivo consistent with the physiology and function ofthe equivalent healthy tissue. We also examine the current trendsin tissue engineering designed to tailor scaffold construction, promoteangiogenesis and identify an optimal seeded cell source.Finally, we describe several currently applied therapeutic modalitiesthat use a tissue-engineered construct. While notable progresshas clearly been demonstrated in this emerging field, these effortshave not yet translated into widespread clinical applicability. Withcontinued development and innovation, there is optimism that thetremendous potential of this field will be realized.L’ingénierie tissulaire englobe une approche multidisciplinaireaxée sur le développement de substituts biologiques en vue derétablir et de maintenir la fonction normale de tissus lésés. L’articlequi suit passe en revue la technologie fondamentale utilisée pourgénérer des greffons implantables produits par ingénierie in vitroet possédant des caractéristiques in vivo correspondant aux tissussains équivalents sur les plans physiologique et fonctionnel.Nous examinons également les tendances actuelles en ingénierietissulaire visant à adapter des échafaudages tissulaires, à promouvoirl’angiogenèse et à dégager une source optimale de cellulesimplantables. Enfin, nous décrivons plusieurs modalités thérapeutiquesactuellement mises en application utilisant un échafaudagecréé par ingénierie tissulaire. En dépit de progrès remarquablesdans ce domaine en effervescence, les efforts déployés ne se sontpas encore traduits par une applicabilité clinique étendue. Desdéveloppements et des percées continus permettent d’être optimisteface au potentiel prodigieux de ce domaine.
APA, Harvard, Vancouver, ISO, and other styles
10

Ikada, Yoshito. "Challenges in tissue engineering." Journal of The Royal Society Interface 3, no. 10 (April 18, 2006): 589–601. http://dx.doi.org/10.1098/rsif.2006.0124.

Full text
Abstract:
Almost 30 years have passed since a term ‘tissue engineering’ was created to represent a new concept that focuses on regeneration of neotissues from cells with the support of biomaterials and growth factors. This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. However, the tissues regenerated by this tissue engineering and widely applied to patients are still very limited, including skin, bone, cartilage, capillary and periodontal tissues. What are the reasons for such slow advances in clinical applications of tissue engineering? This article gives the brief overview on the current tissue engineering, covering the fundamentals and applications. The fundamentals of tissue engineering involve the cell sources, scaffolds for cell expansion and differentiation and carriers for growth factors. Animal and human trials are the major part of the applications. Based on these results, some critical problems to be resolved for the advances of tissue engineering are addressed from the engineering point of view, emphasizing the close collaboration between medical doctors and biomaterials scientists.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tissue engineering"

1

Dawson, Jennifer Elizabeth. "Cardiac Tissue Engineering." Thèse, Université d'Ottawa / University of Ottawa, 2011. http://hdl.handle.net/10393/20071.

Full text
Abstract:
The limited treatment options available for heart disease patients has lead to increased interest in the development of embryonic stem cell (ESC) therapies to replace heart muscle. The challenges of developing usable ESC therapeutic strategies are associated with the limited ability to obtain a pure, defined population of differentiated cardiomyocytes, and the design of in vivo cell delivery platforms to minimize cardiomyocyte loss. These challenges were addressed in Chapter 2 by designing a cardiomyocyte selectable progenitor cell line that permitted evaluation of a collagen-based scaffold for its ability to sustain stem cell-derived cardiomyocyte function (“A P19 Cardiac Cell Line as a Model for Evaluating Cardiac Tissue Engineering Biomaterials”). P19 cells enriched for cardiomyocytes were viable on a transglutaminase cross-linked collagen scaffold, and maintained their cardiomyocyte contractile phenotype in vitro while growing on the scaffold. The potential for a novel cell-surface marker to purify cardiomyocytes within ESC cultures was evaluated in Chapter 3, “Dihydropyridine Receptor (DHP-R) Surface Marker Enrichment of ES-derived Cardiomyocytes”. DHP-R is demonstrated to be upregulated at the protein and RNA transcript level during cardiomyogenesis. DHP-R positive mouse ES cells were fluorescent activated cell sorted, and the DHP-R positive cultured cells were enriched for cardiomyocytes compared to the DHP-R negative population. Finally, in Chapter 4, mouse ESCs were characterized while growing on a clinically approved collagen I/III-based scaffold modified with the RGD integrin-binding motif, (“Collagen (+RGD and –RGD) scaffolds support cardiomyogenesis after aggregation of mouse embryonic stem cells”). The collagen I/III RGD+ and RGD- scaffolds sustained ESC-derived cardiomyocyte growth and function. Notably, no significant differences in cell survival, cardiac phenotype, and cardiomyocyte function were detected with the addition of the RGD domain to the collagen scaffold. Thus, in summary, these three studies have resulted in the identification of a potential cell surface marker for ESC-derived cardiomyocyte purification, and prove that collagen-based scaffolds can sustain ES-cardiomyocyte growth and function. This has set the framework for further studies that will move the field closer to obtaining a safe and effective delivery strategy for transplanting ESCs onto human hearts.
APA, Harvard, Vancouver, ISO, and other styles
2

Somasundaram, Murali. "Intestinal tissue engineering." Thesis, University of Oxford, 2016. https://ora.ox.ac.uk/objects/uuid:54e0f17f-fe04-4012-b0d3-04f436e9af9a.

Full text
Abstract:
Tissue engineering (TE) principles have been successfully clinically applied to treat disease affecting specific organs (e.g. trachea) but developments in some organs has lagged behind. The inability to repair or replace significantly damaged intestinal tissue remains a barrier to improving patient outcomes and the promise of Tissue Engineered Intestine (TEI) that was first made more than 20 years ago, is yet to be realised. This work explored the potential of TEI and literature review formed a basis for developing a clinically transferrable experimental model. It was hypothesised that, porcine large intestine could be retrieved from pigs and decellularized to create a biological scaffold that demonstrated favourable properties for TE, including potential for vascular perfusion and cell engraftment. Novel experiments were performed in intestinal retrieval and decellularization, resulting in scaffolds characterised by a number of methods (e.g. histology, immunohistochemistry). Assessment of the scaffold's ability to support cell engraftment required development of protocols for isolation and culture of appropriate progenitors, including adipose/bone marrow derived mesenchymal stromal cells and intestinal organoid units. Finally, in-vitro cultures combining scaffolds and cells were used to assess the ability of scaffolds to promote tissue regeneration. Perfusion decellularization methods proved effective in creating biological scaffolds that retained radiologically demonstrated vascular perfusion networks, permitting a future route for recellularization and/or transplantation. Scaffolds demonstrated retention of essential extracellular matrix components (e.g. glycosaminoglycans, collagen) and an absence of cell nuclei. Mesenchymal stem cells were isolated, cultured and combined in-vitro with scaffolds in an attempted scaled-down seeding model. Control of culture conditions was challenging and results inconclusive with respect to the scaffold's regenerative potential. The work demonstrates an exciting prospect for biological scaffold development for a clinically transferrable, semi-xenogeneic transplant or drug delivery model but further experiments in scaffold seeding are required to assess the full potential.
APA, Harvard, Vancouver, ISO, and other styles
3

BERNOCCO, MARCO. "Bioreactor engineering for tissue engineering application." Doctoral thesis, Politecnico di Torino, 2013. http://hdl.handle.net/11583/2513796.

Full text
Abstract:
Lo scopo di questo lavoro di tesi è la caratterizzazione metrologica di un bioreattore con l’intento di aumentare la riproducibilità e l’affidabilità dei processi di Ingegneria tessutale (Tissue Engineering, TE). La Tissue engineering (TE) o ingegneria dei tessuti è la disciplina che studia la comprensione dei principi della crescita dei tessuti, e la loro applicazione per produrre tessuto funzionale per uso clinico o diagnostico. Uno dei principali scopi della TE è l’impiego di tessuti in crescita naturale extracorporea per la medicina rigenerativa, in altre parole lo sviluppo di strategie terapeutiche mirate alla sostituzione, riparazione, manutenzione e/o il miglioramento della funzione dei tessuti. L’ingegneria dei tessuti è caratterizzata da una grande interdisciplinarità che prevede la collaborazione di figure professionali con competenze molto differenti tra loro, quali biologi, chimici, fisici, matematici, ingegneri. L’obiettivo è il progetto di un bioreattore che sia affidabile e controllabile per seguire l’evoluzione del processo. Questo deve essere eseguito applicando metodi metrologici allo studio del processo. La metrologia permette di poter quantificare l’incertezza di un fenomeno quindi di determinare la proprietà di un fenomeno, corpo o sostanza, che può essere distinta qualitativamente e determinata quantitativamente. Le fonti d’incertezza che caratterizzano l’incertezza finale o composta è legata: alla mancanza di conoscenza e alla variabilità del sistema e prevede strategie differenti per la loro gestione. La mancanza di conoscenza e può essere ridotta migliorando le informazioni sul sistema in esame, mentre la variabilità del sistema sotto studio, può essere gestita riducendo degli scenari presi in considerazione o definendo più precisamente il sistema studiato.
APA, Harvard, Vancouver, ISO, and other styles
4

Rouwkema, Jeroen. "Prevascularized bone tissue engineering." Enschede : University of Twente [Host], 2007. http://doc.utwente.nl/57929.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mirsadraee, Saeed. "Tissue engineering of pericardium." Thesis, University of Leeds, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426783.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Getgood, Alan Martin John. "Articular cartilage tissue engineering." Thesis, University of Cambridge, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608764.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tseng, Yuan-Tsan. "Heart valve tissue engineering." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:e67c780d-d60f-42e7-9311-dd523f9141b3.

Full text
Abstract:
Since current prosthetic heart valve replacements are costly, cause medical complications, and lack the ability to regenerate, tissue-engineered heart valves are an attractive alternative. These could provide an unlimited supply of immunological-tolerated biological substitutes, which respond to patients' physiological condition and grow with them. Since collagen is a major extra cellular matrix component of the heart valve, it is ideal material for constructing scaffolds. Collagen sources have been shown to influence the manufacturing of collagen scaffolds, and two commercial sources of collagen were obtained from Sigma Aldrich and Devro PLC for comparison. Consistencies between the collagens were shown in the primary and secondary structures of the collagen, while inconsistencies were shown at the tertiary level, when a higher level of natural crosslinking in the Sigma collagen and longer polymer chains in the Devro collagen were observed. These variations were reduced and the consistency increased by introducing crosslinking via dehydrothermal treatment (DHT). Collagen scaffolds produced via freeze-drying (FD) and critical point-drying with cross-linking via DHT or 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide /N-hydroxysuccinimide (EDC/NHS) were investigated. All the scaffolds were compatible with mesenchymal stem cells (MSCs) according to the proliferation of the cells and their ability to produce ECM, without differentiating between osteogenic, chondrogenic or endothelial lineages. The FD EDC/NHS scaffold demonstrated the most suitable physical property of all. This result illustrates that FD EDC/NHS crosslinking is the most suitable scaffold investigated as a start for heart valve tissue engineering. To prepare a scaffold with a controlled local, spatial and temporal delivery of growth factor, a composite scaffold comprising poly (lactic-co-glycolic acid) (PLGA) microspheres was developed. This composite scaffold demonstrated the same compatibility to the MSCs as untreated scaffold. However, the PLGA microspheres showed an increase in the deterioration rate of Young's modulus because of the detachment of the microspheres from the scaffold via cellular degradation.
APA, Harvard, Vancouver, ISO, and other styles
8

Aor, Bruno. "Engineering microchannels for vascularization in bone tissue engineering." Thesis, Bordeaux, 2018. http://www.theses.fr/2018BORD0430/document.

Full text
Abstract:
In vitro, la formation de structures de type tubulaire avec des cellules endothéliales de veine ombilicale humaine (HUVEC) a été étudiée en combinant la fonctionnalisation de la chimie des matériaux et le développement de la géométrie tridimensionnelle. Le polycarbonate (PC) a été utilisé comme modèle pour le développement de l'échafaud. Le film de polysaccharide naturel, basé sur un dépôt alternatif couche par couche (LbL) d’acide hyaluronique (HA) et de chitosane (CHI), a d’abord été appliqué sur une surface PC et caractérisé en termes de croissance d’épaisseur microscopie à balayage lascar (CLSM). Cette première fonctionnalisation se traduit par un revêtement complet de la couche PC. Une biofonctionnalisation supplémentaire avec un peptide adhésif (RGD) et deux peptides angiogénétiques (SVV et QK) a été étudiée, immobilisant ces peptides sur le groupe carboxylique de HA précédemment déposé, en utilisant la chimie bien connue du carbodiimide. La version marquée de chaque peptide a été utilisée pour caractériser l’immobilisation et la pénétration des peptides dans les couches de polyélectrolytes, aboutissant à une greffe réussie avec une pénétration complète dans toute l’épaisseur du LbL. Des tests in vitro ont été effectués à l'aide de cellules HUVEC pour évaluer leur efficacité d'adhésion et leur activité métabolique sur la LbL avec et sans immobilisation de peptides, ce qui a permis d'améliorer l'activité préliminaire lorsque des combinaisons de peptides sont utilisées. Enfin, les micro-canaux PC (μCh) ont été développés et caractérisés pour la première fois, et les autres expériences ont été réalisées sur un micromètre de 25 μm de largeur, fonctionnalisé avec une architecture (HA / CHI) 12,5 (PC-LbL) avec des peptides RGD et QK -RGD + QK) ou avec des peptides RGD et SVV (PC-RGD + SVV). Notre première expérience de tubulogénèse a montré de manière surprenante la formation de structures de type tubulaire déjà après 2h d'incubation en utilisant la combinaison double-peptides, mais uniquement avec PC-RGD + QK. Les tubes étaient également présents après 3 et 4 heures de culture. L'expérience de co-culture avec des péricytes humains dérivés du placenta (hPC-PL) montre comment la stabilisation des tubes a été améliorée après 3 et 4 heures également pour l'échantillon de PC-RGD + SVV. Globalement, notre matériel bio-fonctionnel avec les peptides PC-RGD + QK et PC-RGD + SVV permet la formation d'une structure de type tubulaire à la fois dans une expérience de monoculture et de co-culture
In vitro, tubular-like structures formation with human umbilical vein endothelial cells (HUVECs) was investigated by combining material chemistry functionalization and three-dimensional geometry development. Polycarbonate (PC) was used as a template for the development of the scaffold. Natural polysaccharide’s film based on alternate layer-by-layer (LbL) deposition of hyaluronic acid (HA) and chitosan (CHI), was first applied to PC surface and characterized in terms of thickness growth both, in dry conditions using ellipsometry, and confocal lascar scanning microscopy (CLSM). This first functionalization results in a complete coating of the PC layer. Further biofunctionalization with one adhesive peptide (RGD) and two angiogenetic peptides (SVV and QK) was investigated, immobilizing those peptides on the carboxylic group of HA previously deposited, using the well-known carbodiimide chemistry. The labeled version of each peptide was used to characterize the peptides’ immobilization and penetration into the polyelectrolytes layers, resulting in a successful grafting with complete penetration through the entire thickness of the LbL. In vitro tests were performed using HUVECs to assess their adhesion efficiency and their metabolic activity on the LbL with and without peptide immobilization, resulting in a preliminary improved activity when peptide-combinations is used. Finally, PC micro-channels (μCh) were first developed and characterized, and the rest of the experiments were performed on μCh of 25μm width, functionalized with (HA/CHI)12.5 architecture (PC-LbL) with RGD and QK peptides (PC-RGD+QK) or with RGD and SVV peptides (PC-RGD+SVV). Our first tubulogenesis experiment surprisingly showed the formation of tubular-like structures already after 2h of incubation using the double-peptides combination but only using PC-RGD+QK the tubes were present also after 3 and 4 hours of culture. The co-culture experiment with human pericytes derived from placenta (hPC-PL) demonstrates how the stabilization of the tubes was improved after 3 and 4 hours also for the PC-RGD+SVV sample. Globally our bio-functional material with PC-RGD+QK and PC-RGD+SVV peptides allow the formation of tubular-like structure in both mono and co-culture experiment
APA, Harvard, Vancouver, ISO, and other styles
9

Sodian, Ralf. "Tissue-Engineering von kardiovaskulären Geweben." [S.l.] : [s.n.], 2005. http://deposit.ddb.de/cgi-bin/dokserv?idn=974660175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kamei, Yuzuru, Kazuhiro Toriyama, Toru Takada, and Shunjiro Yagi. "Tissue-Engineering Bone from Omentum." Nagoya University School of Medicine, 2010. http://hdl.handle.net/2237/14172.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Tissue engineering"

1

Morgan, Jeffrey R., and Martin L. Yarmush. Tissue Engineering. New Jersey: Humana Press, 1998. http://dx.doi.org/10.1385/0896035166.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Yoon, Jeong-Yeol. Tissue Engineering. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-83696-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kesharwani, Rajesh K., Raj K. Keservani, and Anil K. Sharma. Tissue Engineering. Boca Raton: Apple Academic Press, 2022. http://dx.doi.org/10.1201/9781003180531.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bell, Eugene, ed. Tissue Engineering. Boston, MA: Birkhäuser Boston, 1993. http://dx.doi.org/10.1007/978-1-4615-8186-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hauser, Hansjörg, and Martin Fussenegger, eds. Tissue Engineering. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-443-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sarvazyan, Narine, ed. Tissue Engineering. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39698-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pallua, Norbert, and Christoph V. Suscheck, eds. Tissue Engineering. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-02824-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fisher, John P., ed. Tissue Engineering. Boston, MA: Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-34133-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fernandes, Paulo Rui, and Paulo Jorge Bartolo, eds. Tissue Engineering. Dordrecht: Springer Netherlands, 2014. http://dx.doi.org/10.1007/978-94-007-7073-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bruns, Jürgen, ed. Tissue Engineering. Heidelberg: Steinkopff, 2003. http://dx.doi.org/10.1007/978-3-642-57353-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Tissue engineering"

1

Mooney, David J., Joseph P. Vacanti, and Robert Langer. "Tissue engineering: Tubular tissues." In Yearbook of Cell and Tissue Transplantation 1996–1997, 275–82. Dordrecht: Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-0165-0_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fon, Deniece, David R. Nisbet, George A. Thouas, Wei Shen, and John S. Forsythe. "Tissue Engineering of Organs: Brain Tissues." In Tissue Engineering, 457–92. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-02824-3_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Silver, Frederick H., and David L. Christiansen. "Tissue Engineering." In Biomaterials Science and Biocompatibility, 305–26. New York, NY: Springer New York, 1999. http://dx.doi.org/10.1007/978-1-4612-0557-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shin, Michael, and Joseph Vacanti. "Tissue Engineering." In Emerging Technologies in Surgery, 133–51. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-39600-0_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Atala, Anthony. "Tissue Engineering." In Pediatric Nephrology, 457–74. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-76341-3_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Daly, Chris Denis, Gordon R. Campbell, and Julie H. Campbell. "Tissue Engineering." In Cardiovascular Research, 207–20. Boston, MA: Springer US, 2006. http://dx.doi.org/10.1007/0-387-23329-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bruley, Duane F. "Tissue Engineering." In Oxygen Transport to Tissue XI, 857–58. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4684-5643-1_97.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wintermantel, Erich, and Suk-Woo Ha. "Tissue Engineering." In Biokompatible Werkstoffe und Bauweisen, 123–35. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-662-06075-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wintermantel, Erich, and Suk-Woo Ha. "Tissue Engineering." In Biokompatible Werkstoffe und Bauweisen, 98–109. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-06077-3_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Liu, Qing. "Tissue Engineering." In Biological and Medical Physics, Biomedical Engineering, 195–243. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-662-06104-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Tissue engineering"

1

Wiltsey, Craig, Thomas Christiani, Jesse Williams, Jamie Coulter, Dana Demiduke, Katelynn Toomer, Sherri English, et al. "Tissue Engineering of the Intervertebral Disc." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80349.

Full text
Abstract:
Tissue engineering is a rapidly growing field of research that aims to repair damaged tissues within the body. Among tissue engineering approaches is the use of scaffolds to help regenerate lost tissues. Scaffolds provide structural support for specific areas within the body, namely load bearing regions, and allow for cells to be seeded within the scaffold for tissue regeneration. Scaffolds that specifically replicate the properties and/or composition of native tissues are referred to as biomimetic scaffolds.
APA, Harvard, Vancouver, ISO, and other styles
2

Lin, Weibin, and Qingjin Peng. "3D Printing Technologies for Tissue Engineering." In ASME 2014 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/detc2014-34408.

Full text
Abstract:
Tissue engineering (TE) integrates methods of cells, engineering and materials to improve or replace biological functions of native tissues or organs. 3D printing technologies have been used in TE to produce different kinds of tissues. Human tissues have intricate structures with the distribution of a variety of cells. For this reason, existing methods in the construction of artificial tissues use universal 3D printing equipment or some simple devices, which is hard to meet requirements of the tissue structure in accuracy and diversity. Especially for soft tissue organs, a professional bio-3D printer is required for theoretical research and preliminary trial. Based on review of the exiting 3D printing technologies used in TE, special requirements of fabricating soft tissues are identified in this research. The need of a proposed bio-3D printer for producing artificial soft tissues is discussed. The bio-3D printer suggested consists of a pneumatic dispenser, a temperature controller and a multi-nozzle changing system.
APA, Harvard, Vancouver, ISO, and other styles
3

Hariri, Alireza, and Jean W. Zu. "Design of a Tissue Resonator Indenter Device for Measurement of Soft Tissue Viscoelastic Properties Using Parametric Identification." In ASME 2009 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. ASMEDC, 2009. http://dx.doi.org/10.1115/detc2009-87786.

Full text
Abstract:
The design of a new device called Tissue Resonator Indenter Device (TRID) for measuring soft tissue viscoelastic properties is presented. The two degrees-of-freedom device works based on mechanical vibration principles. When TRID comes into contact with a soft tissue, it can identify the tissue’s viscoelastic properties through the change of the device’s natural frequencies and damping ratios. In this paper, the deign of TRID is presented assuming Kelvin model for tissues. By working in the linear viscoelastic domain, TRID is designed to identify tissue properties in the range of 0–100 Hz. Assuming Kelvin model for tissues, the current paper develops a method for determining unknown tissue parameters using input-output data from TRID. Moreover, it is proved that the TRID’s parameters as well as the Kelvin tissue model parameters are globally identifiable. A parametric identification method using the prediction error approach is proposed for identifying the unknown tissue parameters in a grey-box state-space model. The reliability and effectiveness of the method for measuring soft tissue’s viscoelastic properties is demonstrated through simulation in the presence of considerable input and output noises.
APA, Harvard, Vancouver, ISO, and other styles
4

Van Mow. ""Functional Tissue Engineering"." In Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.259772.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Toner, Mehmet. "Hepatic Tissue Engineering." In ASME 1996 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1996. http://dx.doi.org/10.1115/imece1996-1212.

Full text
Abstract:
Abstract Each year, approximately 5000 individuals in the United States develop severe enough hepatic failure to require hepatic support. Of these patients, approximately 2000 will undergo orthotopic liver transplantation, currently the only available method for the clinical management of severe hepatic failure. For patients who are not selected for transplantation, there is no adequate treatment available. Those suffering from cirrhosis fight the seventh-leading cause of death in the United States and those suffering from acute liver failure face a mortality of greater than 80%. Although the replacement of liver function using nonbiological, biological, and semibiological or hybrid approaches his been attempted by many investigators, no means for reliable liver replacement, other than organ transplantation, currently exists. One of the most promising approaches for restoring liver function involves the use of cultured hepatocytes that would be part of an extracorporeal device. For a successful extracorporeal device containing stable and functioning hepatocytes, several critical technologies need further development including techniques for (1) long-term hepatocyte culture and methods for reconstructing “in-vivo-like” liver tissue in vitro (2) hepatocyte cryopreservation, and (3) effect of plasma perfusion or in-vivo like fluids on hepatocytes. In this presentation, we will review some of our most recent progress in these three areas. The following is a brief summary.
APA, Harvard, Vancouver, ISO, and other styles
6

Butler, David L. "A Paradigm for Functional Tissue Engineering." In ASME 2000 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2000. http://dx.doi.org/10.1115/imece2000-2497.

Full text
Abstract:
Abstract Clinicians, biologists, and engineers face difficult challenges in engineering effective, cell-based composites for repair of orthopaedic and cardiovascular tissues. Whether repairing articular cartilage, bone, or blood vessel, the demands placed on the surgical implants can threaten the long-term success of the procedure. In 1998, the US National Committee on Biomechanics addressed this problem by suggesting a new paradigm for tissue engineering called “functional tissue engineering” or FTE. FTE seeks to address several important questions. What are the biomechanical demands placed upon the normal tissue and hence the tissue engineered implant after surgery? What parameters should a tissue engineer design into the implant before surgery? And what biomechanical parameters should the tissue engineer track to determine if the resulting repair is successful? To illustrate the principles, this presentation will discuss tendon repair as a model system for functional tissue engineering.
APA, Harvard, Vancouver, ISO, and other styles
7

Morgan, Jeffrey R. "Genetic Strategies for Tissue Engineering." In ASME 1996 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1996. http://dx.doi.org/10.1115/imece1996-1165.

Full text
Abstract:
Abstract Recent advances in molecular genetics have resulted in the development of new technologies for the introduction and expression of genes in human somatic cells. These gene transfer technologies have given rise to a potentially new field of medical treatment known as gene therapy. Gene therapy is broadly defined as the transfer of genetic material to cells or tissues in order to achieve a therapeutic effect for inherited as well as acquired diseases. We are exploring the potential application of gene transfer technologies to the field of tissue engineering and are interested in determining if genetic modification can be used to enhance the function and/or performance of cells used as or part of biological substitutes for the restoration, maintenance or improvement of tissue function. We believe that gene transfer technologies will be an important addition to the field of tissue engineering.
APA, Harvard, Vancouver, ISO, and other styles
8

Kim, Sang-Heon, Youngmee Jung, Soo Hyun Kim, and Young Ha Kim. "Mechano-active Tissue Engineering." In In Commemoration of the 1st Asian Biomaterials Congress. WORLD SCIENTIFIC, 2008. http://dx.doi.org/10.1142/9789812835758_0007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ranieri, John P. "Tissue Engineering: A Review." In ASME 1996 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1996. http://dx.doi.org/10.1115/imece1996-1162.

Full text
Abstract:
Abstract Tissue engineering is defined as the in vitro or in vivo creation or regeneration of differentiated tissue for the clinical replacement of a compromised body structure. The ultimate goal of tissue engineering is to reconstruct an organ by taking advantage of recent progress in molecular biology (i.e., mechanisms controlling cell differentiation and gene transfer), materials science (development of “smart” and bioresorbable polymers), and surgical techniques. Tissue engineering is not so much a science in the traditional sense, but an amalgam of technologies from disparate fields that are grouped such that clinically relevant tissue replacement therapies may result.
APA, Harvard, Vancouver, ISO, and other styles
10

Parenteau, Nancy L., Susan Sullivan, and Maury D. Cosman. "Tissue Engineering: Interdisciplinary, Multi-Disciplinary Technology." In ASME 2000 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2000. http://dx.doi.org/10.1115/imece2000-2499.

Full text
Abstract:
Abstract Tissue engineering is the use of engineering and biology for the repair, replacement or regeneration of tissues. It often requires multiple disciplines within engineering and the biological sciences. Each problem is unique in its requirements. While the intent may differ, e.g. structural repair, physiological correction, chemical delivery, or a combination, most applications will require multi-disciplinary input.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Tissue engineering"

1

Patrick, Charles W., and Jr. Breast Reconstruction Using Tissue Engineering. Fort Belvoir, VA: Defense Technical Information Center, September 2001. http://dx.doi.org/10.21236/ada400643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Patrick, Charles W., and Jr. Breast Reconstruction Using Tissue Engineering. Fort Belvoir, VA: Defense Technical Information Center, September 2002. http://dx.doi.org/10.21236/ada410572.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ingber, Donald, Mark Puder, and Joyce Bischoff. Angiogenesis and Tissue Engineering Research. Fort Belvoir, VA: Defense Technical Information Center, August 2010. http://dx.doi.org/10.21236/ada524972.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Patrick, Charles W., and Jr. Breast Reconstruction Using Tissue Engineering. Fort Belvoir, VA: Defense Technical Information Center, September 2003. http://dx.doi.org/10.21236/ada420386.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bashir, Rashid. Micro and Nano-mediated 3D Cardiac Tissue Engineering. Fort Belvoir, VA: Defense Technical Information Center, October 2010. http://dx.doi.org/10.21236/ada604913.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Porat, Ron, Doron Holland, and Linda Walling. Identification of Citrus Fruit-Specific and Pathogen-Induced Promoters and Their Use in Molecular Engineering. United States Department of Agriculture, January 2001. http://dx.doi.org/10.32747/2001.7585202.bard.

Full text
Abstract:
This one year BARD project was funded to develop methods to monitor promoter activity a gene expression patterns in citrus fruit. To fulfill this goal, we divided the research tasks between both labs so that the Israeli side evaluated the use of microprojectile bombardment ; a tool to evaluate transient gene expression in various citrus fruit tissues, and the US side optimized technical parameters required for Agrobacterium-mediated transformation of various citrus cultivars. Microprojectile bombardment appeared to be a very efficient method for transient gene expression analysis in citrus leaf tissues but was somewhat less applicable in fruit tissues. Nevertheless, we did succeeded to achieve significant levels of 35S-GUS gene expression in young green flavedo tissue. However, only single random spots of 35S-GUS gene expression were detected mature flavedo and in juice sacs and albedo tissue. Overall, we assume that following some more technical improvements particle bombardment could provide a useful technique to rapidly analyze promoter activity at least in the flavedo tissue. For Agrobacterium-mediated transformation, we found that shoot cultures of 'Washington' navel oranges,'Fairchild' mandarins,'Eureca' lemons,'Troyer' citrange and various grapefruits provided a more reliable and consistent source of tissue for transformation than germinated seedlings. Moreover, various growth media's (McCown, Quoirin & Lepoivre, DCR) further improved shoot and root growth relative to MS mineral media, which is commonly used. Also pure white light (using bulbs which do not emit UV or blue light) improved shoot growth in various citrus varieties, and paromomycin appeared to be a more efficient antibiotic for the selection of transgenic plants than Kanamycin. Overall, these optimizations improve transformation efficacy and shoot growth and rooting capacity. In addition to the development of transformation methods, both Israeli and US labs achieved progress in the identification of citrus fruit-specific promoters. In Israel, we isolated a 3.6 kb promoter fragment of the thiamine biosynthesis c-thi gene, which is highly expressed in fruit peel tissue, whereas in the US we isolated a 1.5 kb promoter fragment of the citrus seed-specific cDNA CssH. The identification of more fruit-specific cDNAs and their corresponding promoter regions is currently in progress.
APA, Harvard, Vancouver, ISO, and other styles
7

Davis, George. Tissue Engineering of Dermal Blood and Lymphatic Microvascular Networks. Fort Belvoir, VA: Defense Technical Information Center, March 2014. http://dx.doi.org/10.21236/ada602466.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Huard, Johnny. Articular Cartilage Repair Through Muscle Cell-Based Tissue Engineering. Fort Belvoir, VA: Defense Technical Information Center, March 2011. http://dx.doi.org/10.21236/ada552048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Osman, Nadir, and Christopher Chapple. The role of tissue engineering for urethral stricture disease. BJUI Knowledge, January 2020. http://dx.doi.org/10.18591/bjuik.0690.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nielson, Olivia, Dave Estrada, Mone't Alberts, Josh Eixenberger, and Raquel Brown. Optimizing ATDC5 Seeding of Graphene Foam for Cartilage Tissue Engineering. Peeref, July 2022. http://dx.doi.org/10.54985/peeref.2207p1842808.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Tissue engineering' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography